Risk of Bleeding in End-Stage Liver Disease Patients Undergoing Cardiac Catheterization

Area of Science:

• Cardiology
• Hepatology
• Interventional Procedures

Background:

• Patients with end-stage liver disease (ESLD) often present with coagulopathies, increasing bleeding risk during invasive procedures.
• The international normalized ratio (INR) is commonly used to assess bleeding tendency, but its role in guiding interventions before cardiac catheterization in ESLD patients remains debated.
• While the radial approach is proven superior to femoral access for reducing bleeding in general populations, its specific benefit in ESLD patients is less understood.

Purpose of the Study:

• To review existing studies on cardiac catheterization in patients with end-stage liver disease.
• To discuss the effectiveness of current methods for reducing bleeding risk in this patient group.
• To evaluate the potential benefits of the radial approach in ESLD patients undergoing cardiac catheterization.

Main Methods:

• Literature review of studies involving cardiac catheterization in patients with end-stage liver disease.
• Analysis of data comparing radial versus femoral access for cardiac catheterization.
• Discussion of pharmacologic and non-pharmacologic interventions to manage coagulopathy.

Main Results:

• The radial approach has demonstrated superiority over femoral access in reducing bleeding complications during cardiac catheterization in the general population.
• Bleeding reduction via the radial approach can decrease the need for and cost of blood product transfusions.
• Evidence specifically addressing the radial approach's efficacy and safety in end-stage liver disease patients is limited.

Conclusions:

• The optimal strategy for managing coagulopathy and reducing bleeding risk during cardiac catheterization in end-stage liver disease patients requires further investigation.
• The radial approach shows promise for improving safety in this population, but more targeted research is essential.
• Current practices for international normalized ratio measurement and subsequent interventions in ESLD patients undergoing procedures need continued evaluation.